NO991292L - Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser - Google Patents

Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser

Info

Publication number
NO991292L
NO991292L NO991292A NO991292A NO991292L NO 991292 L NO991292 L NO 991292L NO 991292 A NO991292 A NO 991292A NO 991292 A NO991292 A NO 991292A NO 991292 L NO991292 L NO 991292L
Authority
NO
Norway
Prior art keywords
neurological disorders
spasticity
benzopyranols
neuralgia
disorders
Prior art date
Application number
NO991292A
Other languages
English (en)
Other versions
NO991292D0 (no
Inventor
Andrew A Parsons
Mervyn Thompson
Neil Upton
John Morris Evans
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO991292L publication Critical patent/NO991292L/no
Publication of NO991292D0 publication Critical patent/NO991292D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Det beskrives benzopyranderivater og analoger som er egnet for behandling og/eller forebyggelse av degenerative sykdommer, så som Huntingtons chorea, schizofreni, nevrologiske svikt assosiert med AIDS, søvnforstyrrelser (inklusivt døgnrytmeforstyrrelser, insomni og narkolepsi), ties (f.eks. Tourettes syndrom), traumatisk hjerneskade, tinnitus, nevralgi, spesielt trigeminusnevralgi, nevropatisk smerte, tannverk, smerter ved kreft, feilaktig nerveaktivitet som resulterer i nevrodysestesi ved sykdommer som diabetes, MS og motonevronsykdom, ataksier, muskelstivhet (spastisitet) og svikt i temporomandibularis-leddet.
NO991292A 1996-09-18 1999-03-17 Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser NO991292D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment
PCT/EP1997/005168 WO1998011890A1 (en) 1996-09-18 1997-09-15 Use of benzopyranols to treat neurological disorders

Publications (2)

Publication Number Publication Date
NO991292L true NO991292L (no) 1999-03-17
NO991292D0 NO991292D0 (no) 1999-03-17

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991292A NO991292D0 (no) 1996-09-18 1999-03-17 Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser

Country Status (30)

Country Link
EP (1) EP0939630B1 (no)
JP (1) JP2001500520A (no)
KR (1) KR20000036184A (no)
CN (1) CN1230885A (no)
AP (1) AP9901473A0 (no)
AR (1) AR008838A1 (no)
AT (1) ATE270102T1 (no)
AU (1) AU730465B2 (no)
BG (1) BG103252A (no)
BR (1) BR9712030A (no)
CA (1) CA2266681A1 (no)
DE (1) DE69729735T2 (no)
DZ (1) DZ2311A1 (no)
EA (1) EA199900306A1 (no)
ES (1) ES2223075T3 (no)
GB (1) GB9619492D0 (no)
HU (1) HUP9904638A3 (no)
ID (2) ID23175A (no)
IL (1) IL128786A0 (no)
MA (1) MA24321A1 (no)
NO (1) NO991292D0 (no)
NZ (1) NZ334271A (no)
OA (1) OA10998A (no)
PE (1) PE109898A1 (no)
PL (1) PL332313A1 (no)
SK (1) SK35199A3 (no)
TR (1) TR199900527T2 (no)
UY (1) UY24717A1 (no)
WO (1) WO1998011890A1 (no)
ZA (1) ZA978359B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20130281524A1 (en) * 2008-06-05 2013-10-24 Peter Blower Novel treatments
MX2010013312A (es) * 2008-06-05 2011-05-30 Minster Res Ltd Tratamientos novedoos.
ES2642586T3 (es) 2009-07-27 2017-11-16 Gilead Sciences, Inc. Compuestos heterocíclicos condensados como moduladores de canales iónicos
US20130018091A1 (en) * 2009-12-03 2013-01-17 Peter Blower Treatment of allodynia and hyperalgesia
EP2506847A1 (en) * 2009-12-03 2012-10-10 Proximagen Limited Treatment of infectious diseases
EP2588197B1 (en) 2010-07-02 2014-11-05 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
KR20140033377A (ko) 2011-05-10 2014-03-18 길리애드 사이언시즈, 인코포레이티드 나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물
NO3175985T3 (no) 2011-07-01 2018-04-28
UY34171A (es) 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
CN1174975C (zh) * 1994-06-10 2004-11-10 史密丝克莱恩比彻姆有限公司 苯并吡喃类化合物和它们作为治疗剂的用途
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
EP0939630A1 (en) 1999-09-08
AR008838A1 (es) 2000-02-23
AU730465B2 (en) 2001-03-08
BG103252A (en) 1999-09-30
DZ2311A1 (fr) 2002-12-28
HUP9904638A2 (hu) 2001-05-28
JP2001500520A (ja) 2001-01-16
EA199900306A1 (ru) 1999-08-26
PL332313A1 (en) 1999-08-30
SK35199A3 (en) 2000-07-11
MA24321A1 (fr) 1998-04-01
ATE270102T1 (de) 2004-07-15
CA2266681A1 (en) 1998-03-26
ZA978359B (en) 1999-03-17
UY24717A1 (es) 2001-08-27
HUP9904638A3 (en) 2001-08-28
AU4704797A (en) 1998-04-14
PE109898A1 (es) 1999-03-21
BR9712030A (pt) 1999-08-24
KR20000036184A (ko) 2000-06-26
CN1230885A (zh) 1999-10-06
AP9901473A0 (en) 1999-03-31
TR199900527T2 (xx) 1999-06-21
EP0939630B1 (en) 2004-06-30
ES2223075T3 (es) 2005-02-16
WO1998011890A1 (en) 1998-03-26
GB9619492D0 (en) 1996-10-30
ID23175A (id) 2000-03-23
DE69729735T2 (de) 2005-07-14
ID19542A (id) 1998-07-23
DE69729735D1 (de) 2004-08-05
NO991292D0 (no) 1999-03-17
NZ334271A (en) 2001-03-30
OA10998A (en) 2003-03-04
IL128786A0 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE381935T1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
DE69533040D1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
PT822829E (pt) Utilizacao do factor neurotrofico da glia (gdnf) para o tratamento de desordens da audicao
DE60042137D1 (de) Rekombinante alpha-l-iduronidase und behandlung von durch diese hervorgerufene mangelerkrankungen
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
NO991292L (no) Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser
ES2194025T3 (es) Toxinas botulinicas multiples para tratar trastornos y enfermedades neuromusculares.
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE59907752D1 (de) Verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien
FR2721516B1 (fr) Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.
ATE289800T1 (de) Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems
MY134778A (en) Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
DE69617856D1 (de) Methoden zur behandlung von atemwegserkrankungen
ZA865735B (en) Pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
Latha et al. Efficacy of yoga therapy in the management of headaches.
WO2003057162A3 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
MY120530A (en) Combination preparation for use in dementia
MXPA03001160A (es) Metodo para tratar desordenes neurodegenerativos de la retina y cabeza de nervio optico.
PH22534A (en) Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide
WO2002030411A8 (en) Treatment of apoptotic cell death
ATE260108T1 (de) Verwendung von citicoline zur behandlung von multipler sklerose
GR3033061T3 (en) Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE320263T1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application